Firms ally to develop drugs for rare genetic disorders

Nimbus Discovery and Shire agreed to collaborate in the discovery and development of small molecule drugs for lysosomal storage disorders using the former's computational chemistry platform. Nimbus will be in charge of discovery, and Shire will handle clinical development and commercialization. The deal entitles Nimbus to undisclosed milestone payments.

View Full Article in:

Genetic Engineering & Biotechnology News · Boston Herald

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
European Sales Manager
SentreHEART, Inc.
Germany, Benelux, UK
REG AFFAIRS PROJ MGR - 1400000A7F
Abbott
San Jose, CA
SPECIALIST II SYSTEMS INTEGRATION - 140000033P
Abbott
Dallas, TX
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD